BioSyent (RX) Stock Chart & Stock Price History C$10.43 +0.04 (+0.38%) As of 12:24 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesInsider TradesBuy This Stock BioSyent Stock Price Performance 5 Day Performance-1.05%1 Month Performance-6.82%3 Month Performance-6.14%6 Month Performance-6.98%Year-To-Date Performance-5.55%1 Year Performance+23.69% Receive RX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter. Email Address RX Stock Chart for Thursday, April, 24, 2025 RX Chart by TradingView BioSyent Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2025C$10.29C$10.39+0.97%C$10.48C$10.301,769 shsC$118.84 million04/22/2025C$10.26C$10.29+0.29%C$10.50C$10.29306 shsC$117.69 million04/21/2025C$10.50C$10.26-2.29%C$10.65C$10.251,000 shsC$117.35 million04/18/2025C$10.50C$10.50C$10.50C$10.50100 shsC$120.09 million04/17/2025C$10.74C$10.50-2.23%C$10.50C$10.50100 shsC$120.09 million04/16/2025C$10.26C$10.74+4.68%C$10.74C$10.252,860 shsC$122.84 million04/15/2025C$10.00C$10.26+2.60%C$10.30C$9.954,649 shsC$117.35 million04/14/2025C$10.36C$10.00-3.47%C$10.70C$10.0028,720 shsC$114.37 million04/11/2025C$10.00C$10.36+3.60%C$10.36C$10.36106 shsC$118.49 million04/10/2025C$10.48C$10.00-4.58%C$10.40C$10.002,312 shsC$114.37 million Get the Latest News and Ratings for RX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter. 04/09/2025C$10.05C$10.48+4.28%C$10.49C$10.05500 shsC$119.86 million04/09/2025C$10.05C$10.48+4.28%C$10.49C$10.05500 shsC$119.86 million04/08/2025C$10.15C$10.05-0.99%C$10.20C$10.054,041 shsC$114.95 million04/08/2025C$10.15C$10.05-0.99%C$10.20C$10.054,041 shsC$114.95 million04/07/2025C$9.90C$10.15+2.53%C$10.15C$9.2021,894 shsC$116.09 million04/04/2025C$10.80C$9.90-8.33%C$11.12C$9.904,330 shsC$113.23 million04/03/2025C$10.87C$10.80-0.64%C$11.13C$10.77869 shsC$123.52 million04/02/2025C$10.95C$10.87-0.73%C$11.00C$10.871,878 shsC$124.33 million04/01/2025C$11.15C$10.95-1.79%C$11.05C$10.95666 shsC$125.24 million03/31/2025C$11.15C$11.15C$11.15C$11.15203 shsC$127.53 million03/28/2025C$11.36C$11.15-1.85%C$11.29C$11.15770 shsC$127.53 million03/27/2025C$11.30C$11.36+0.53%C$11.36C$11.257,789 shsC$129.93 million03/26/2025C$11.30C$11.30C$11.30C$11.301,158 shsC$129.24 million03/25/2025C$11.15C$11.30+1.35%C$11.30C$11.101,889 shsC$129.24 million03/24/2025C$11.30C$11.15-1.33%C$11.18C$11.15651 shsC$127.53 million Related Companies Tilray Brands Stock Price Chart Aurora Cannabis Stock Price Chart Canopy Growth Stock Price Chart Cipher Pharmaceuticals Stock Price Chart Organigram Stock Price Chart Cardiol Therapeutics Stock Price Chart HLS Therapeutics Stock Price Chart SugarBud Craft Growers Stock Price Chart Medexus Pharmaceuticals Stock Price Chart MediPharm Labs Stock Price Chart Receive RX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:RX) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredA Biotech Power Move? This company is leading the charge in developing advanced antiviral therapies—watch closely!With a revolutionary antiviral drug, this company is in a great position to build shareholder value as this ti...Smallcaps Daily | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSyent Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSyent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.